Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2025-12-29 @ 5:36 PM
Study NCT ID:
NCT04067492
Status:
TERMINATED
Last Update Posted:
2022-07-25
First Post:
2019-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
Sponsor:
R-Pharm
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-26
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-12
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-05
First Submit QC Date:
None
Study First Post Date:
2019-08-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-03-23
Results First Submit QC Date:
None
Results First Post Date:
2022-07-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-23
Last Update Post Date:
2022-07-25
Last Update Post Date Type:
ACTUAL